Table 2.
ALK inhibitor | Crizotinib | Ceretinib | Alectinib | PF-06463922 |
---|---|---|---|---|
Resistance mutation | ||||
G1123S | Resistant [113] | Sensitive [113] | ||
1151Tins | Resistant [79, 90] | Resistant [90] | Resistant [79] | Sensitive [87] |
L1152P/R | Resistant [90] | Resistant [90] | Sensitive [114] | Sensitive [87] |
C1156Y/T | Resistant [90] | Resistant [90] | Sensitive [87] | Sensitive [87] |
I1171T/N | Resistant [90] | Sensitive [90, 115, 116] | Resistant [115, 116] | Sensitive [87] |
F1174L/C | Resistant [90] | Resistant [90] | Sensitive [115] | Sensitive [87] |
V1180L | Resistant [115] | Sensitive [115] | Resistant [115] | Sensitive [87] |
L1196M | Resistant [78, 79, 83] | Sensitive [90] | Sensitive [87] | Sensitive [87] |
G1202R | Resistant [79, 90] | Resistant [84, 90] | Resistant [79] | Sensitive [72, 87] |
S1206Y | Resistant [79, 90] | Sensitive [90] | Sensitive [79] | Sensitive [87] |
G1269A/S | Resistant [90] | Sensitive [90] | Sensitive [114] | Sensitive [87] |